| Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy LF Mager, R Burkhard, N Pett, NCA Cooke, K Brown, H Ramay, S Paik, ... Science 369 (6510), 1481-1489, 2020 | 949 | 2020 |
| Cytokine-induced modulation of colorectal cancer LF Mager, MH Wasmer, TT Rau, P Krebs Frontiers in oncology 6, 96, 2016 | 271 | 2016 |
| The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer E Pastille, MH Wasmer, A Adamczyk, VP Vu, LF Mager, NNT Phuong, ... Mucosal immunology 12 (4), 990-1003, 2019 | 143 | 2019 |
| IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms LF Mager, C Riether, CM Schürch, Y Banz, MH Wasmer, R Stuber, ... The Journal of clinical investigation 125 (7), 2579-2591, 2015 | 105 | 2015 |
| The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice KD Mertz, LF Mager, MH Wasmer, T Thiesler, VH Koelzer, G Ruzzante, ... Oncoimmunology 5 (1), e1062966, 2016 | 103 | 2016 |
| TREM-1 promotes intestinal tumorigenesis L Saurer, D Zysset, S Rihs, L Mager, M Gusberti, C Simillion, A Lugli, ... Scientific reports 7 (1), 14870, 2017 | 53 | 2017 |
| The ESRP1-GPR137 axis contributes to intestinal pathogenesis LF Mager, VH Koelzer, R Stuber, L Thoo, I Keller, I Koeck, ... Elife 6, e28366, 2017 | 29 | 2017 |
| Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice A Neunkirchner, B Kratzer, C Köhler, U Smole, LF Mager, KG Schmetterer, ... EBioMedicine 31, 66-78, 2018 | 28 | 2018 |
| Exercise and Prebiotic fiber provide gut Microbiota-driven benefit in a survivor to germ-free Mouse Translational model of breast cancer K Sampsell, W Wang, C Ohland, LF Mager, N Pett, DE Lowry, KM Sales, ... Cancers 14 (11), 2722, 2022 | 14 | 2022 |
| Impact of the microbiome on tumor immunity KD McCoy, LF Mager Current Opinion in Immunology 69, 39-46, 2021 | 11 | 2021 |
| Cytokine-induced modulation of colorectal cancer. Front Oncol. 2016; 6: 96 LF Mager, MH Wasmer, TT Rau, P Krebs | 10 | 2016 |
| The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology 5, e1062966 KD Mertz, LF Mager, MH Wasmer, T Thiesler, VH Koelzer, G Ruzzante, ... | 4 | 2016 |
| Intestinal colonization regulates systemic anti-commensal immune sensitivity and hyperreactivity R Burkhard, M Koegler, K Brown, K Wilson, LF Mager, AZ Zucoloto, ... Frontiers in Immunology 14, 1030395, 2023 | 2 | 2023 |
| Immunotherapy efficacy in colorectal cancer is dependent on activation of a microbial-metabolite-immune circuit LF Mager, R Burkhard, NCA Cooke, K Brown, H Ramay, S Paik, J Stagg, ... BioRxiv, 2020.02. 26.965533, 2020 | 1 | 2020 |
| Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis S Schuehle, E Kotsiliti, M Qiu, Y Cohen, S Deng, H Omer, F Han, ... Zeitschrift für Gastroenterologie 63 (01), P3. 29, 2025 | | 2025 |
| OS-103 Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis S Schuehle, E Kotsiliti, Y Cohen, S Deng, H Omer, F Han, M Qiu, ... Journal of Hepatology 80, S65, 2024 | | 2024 |
| Interaction of microbiota, mucosal malignancies, and immunotherapy-mechanistic insights LF Mager, T Krause, KD McCoy Mucosal Immunology, 2024 | | 2024 |
| The inositol phosphatase SHIP restrains type 2 innate lymphoid cell-induced airway inflammation J Yeoh, MH Wasmer, N Kirschke, LF Mager, S Berezowska, C von Garnier, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 18-18, 2022 | | 2022 |
| Harnessing the power of microbiota and metabolites for the treatment of cancer KD Mccoy, LF Mager | | 2021 |
| Author response: The ESRP1-GPR137 axis contributes to intestinal pathogenesis LF Mager, VH Koelzer, R Stuber, L Thoo, I Keller, I Koeck, ... | | |
